Johnson, Benny
Kopetz, Scott http://orcid.org/0000-0001-9647-3416
Article History
First Online: 5 September 2020
Declarations
:
: Cancer Center Support Grant (CCSG) CA016672; National Institutes of Health/National Cancer Institute (NIH/NCI) R01 CA187238, R01 CA184843 and MD Anderson Moon Shots.
: Dr. Johnson serves as a consultant/clinical advisory board for Gritstone Oncology. Dr. Kopetz serves as a consultant/clinical advisory board for Merck, Navire Pharma, Holy Stone, Biocartis, Natera, Roche, Redx Pharma, Jacobio, Genentech, Lilly, AstraZeneca/MedImmune, EMD Serono, Daiichi Sankyo, Karyopharm Therapeutics, EMD Serono, Symphogen, Novartis, Boston Biomedical, Ipsen, HalioDx, Amgen, Pierre Fabre, Amal Therapeutics, Boehringer Ingelheim, Bayer Health, Lutris, Pfizer.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Benny Johnson and Scott Kopetz provided equally to the contribution of this article.